CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-18 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −30,706 | $0.84 | $26K | 283,774 |
| 2026-08-17 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −37,256 | $0.72 | $27K | 314,480 |
| 2026-08-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion 10b5-1 | +170,000 | 351,736 | ||
| 2026-08-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion · Restricted Stock Units 10b5-1 | −170,000 | 0 | ||
| 2026-02-18 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −34,939 | $1.58 | $55K | 181,736 |
| 2026-02-17 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −32,771 | $1.54 | $50K | 216,675 |
| 2026-02-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion 10b5-1 | +165,000 | 249,446 | ||
| 2026-02-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion · Restricted Stock Units 10b5-1 | −165,000 | 170,000 | ||
| 2026-01-29 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +820,000 | 820,000 | ||
| 2025-08-19 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −49,402 | $0.57 | $28K | 84,446 |
| 2025-08-18 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −33,352 | $0.65 | $22K | 133,848 |
| 2025-08-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion 10b5-1 | +165,000 | 167,200 | ||
| 2025-08-15 | Andersen Jill Chief Legal Officer, Secretary | Exercise or conversion · Restricted Stock Units 10b5-1 | −165,000 | 335,000 | ||
| 2025-02-15 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +950,000 | 950,000 | ||
| 2025-02-15 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2023-12-18 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-11-17 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2022-12-14 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2022-11-03 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2022-01-30 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +575,000 | 575,000 |
Page 1 of 2 · 21 trades